NASDAQ:RSLS - Nasdaq - US76090R3093 - Common Stock - Currency: USD
Taking everything into account, RSLS scores 2 out of 10 in our fundamental rating. RSLS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While RSLS seems to be doing ok healthwise, there are quite some concerns on its profitability. RSLS has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -53.42% | ||
ROE | -281.54% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -139.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.53 | ||
Quick Ratio | 0.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
2.39
+0.01 (+0.42%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.8 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 4.64 | ||
P/tB | 4.64 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -53.42% | ||
ROE | -281.54% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.74% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.53 | ||
Quick Ratio | 0.91 | ||
Altman-Z | -139.52 |